Diana Harshbarger (R-TN)
United States-Abraham Accords Cooperation and Security Act of 2025
A Republican bill with 4 Democratic cosponsors · See all 6 cosponsors
Last activity — Referred to the House Committee on Energy and Commerce.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
This bill, titled the "United States-Abraham Accords Cooperation and Security Act of 2025," aims to amend the Federal Food, Drug, and Cosmetic Act. It directs the Secretary, through the FDA Commissioner, to establish an Abraham Accords Office. This office will be located in an Abraham Accords country and headed by a director. The office's duties include providing technical assistance to regulatory partners and facilitating interactions regarding regulated products. Additionally, the Secretary must submit a report to Congress regarding the office's progress within three years.
Yes· 3 of 4
- Scored +5
Does this strengthen ties with allied countries?
The bill establishes a dedicated office to strengthen regulatory and technical cooperation with Abraham Accords countries.
- Scored +3
Does this make it easier to run a small business?
The bill facilitates interactions between the FDA and interested parties regarding regulatory pathways and manufacturing.
- Scored +2
Does this make health care easier to get in general?
By converging regulatory requirements and manufacturing standards, the bill aims to streamline the availability of regulated medical products.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Technical Assistance for Regulatory Oversight: The office will provide technical assistance to regulatory partners in Abraham Accords countries to strengthen oversight and converge regulatory requirements, including good manufacturing practices (Section 1015(c)(1)(A)).
-
Improved Communication and Information Sharing: The office will facilitate interactions between the FDA and interested parties in Abraham Accords countries by sharing information about U.S. regulatory pathways and gathering feedback on research, development, and manufacturing (Section 1015(c)(1)(B)).
Potential Negative Impacts for People
- No specific negative impacts or burdens are explicitly identified in the provided text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- National Security And Foreign Policy
- Does this strengthen ties with allied countries? — The bill establishes a dedicated office to strengthen regulatory and technical cooperation with Abraham Accords countries.
- Healthcare
- Does this make health care easier to get in general? — By converging regulatory requirements and manufacturing standards, the bill aims to streamline the availability of regulated medical products. Does this put more money into medical research? — The bill facilitates feedback on the research and development of products regulated by the FDA.
- Economy And Finance
- Does this make it easier to run a small business? — The bill facilitates interactions between the FDA and interested parties regarding regulatory pathways and manufacturing.
- 1/30/2026
- 1 Cosponsor added.
- 3/3/2025
- Referred to the House Committee on Energy and Commerce.
- 5 Cosponsors added.
- Introduced in House
4 bills Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Josh GottheimerDemocrat · New Jersey
Andy HarrisRepublican · Maryland
Mike LevinDemocrat · California
Scott PetersDemocrat · California
Juan VargasDemocrat · California
Randy WeberRepublican · Texas